Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

RXST

RxSight Inc

Feb 13 • 04:00PM ET

8.04

+0.24 3.08 %

Healthcare • Medical Devices • USA • NASD

Peers: STAA ALGN ICUI EW BSX MDT SYK TFX BAX XRAY

| Held by: VTI IWM VXF IWO VTWO SCHA VHT XHE DFAS ITOT

Index	RUT	P/E	-	EPS (ttm)	-0.88	Insider Own	6.26%	Shs Outstand	41.08M	Perf Week	-4.17%
Market Cap	330.58M	Forward P/E	-	EPS next Y	-1.11	Insider Trans	0.00%	Shs Float	38.54M	Perf Month	-16.86%
Enterprise Value	114.62M	PEG	-	EPS next Q	-0.33	Inst Own	82.75%	Short Float	10.75%	Perf Quarter	-19.68%
Income	-35.73M	P/S	2.33	EPS this Y	-50.09%	Inst Trans	-12.37%	Short Ratio	4.35	Perf Half Y	-2.19%
Sales	142.09M	P/B	1.20	EPS next Y	-4.03%	ROA	-11.54%	Short Interest	4.14M	Perf YTD	-22.84%
Book/sh	6.72	P/C	1.45	EPS next 5Y	-14.11%	ROE	-12.92%	52W High	32.24 -75.07%	Perf Year	-74.77%
Cash/sh	5.53	P/FCF	-	EPS past 3/5Y	26.50% -	ROIC	-12.48%	52W Low	6.32 27.22%	Perf 3Y	-39.87%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	83.64% 128.61%	Gross Margin	74.98%	Volatility	5.76% 6.09%	Perf 5Y	-
Dividend TTM	-	EV/Sales	0.81	EPS Y/Y TTM	-7.15%	Oper. Margin	-32.01%	ATR (14)	0.57	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.44	Sales Y/Y TTM	10.75%	Profit Margin	-25.15%	RSI (14)	35.76	Recom	3.09
Dividend Gr. 3/5Y	- -	Current Ratio	12.74	EPS Q/Q	-50.41%	SMA20	-8.60%	Beta	1.15	Target Price	10.39
Payout	-	Debt/Eq	0.04	Sales Q/Q	-14.09%	SMA50	-21.88%	Rel Volume	0.54	Prev Close	7.80
Employees	498	LT Debt/Eq	0.04	Earnings	Feb 25 AMC	SMA200	-23.09%	Avg Volume	952.22K	Price	8.04
IPO	Jul 30, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	36.12% 19.87%	Trades		Volume	509,526	Change	3.08%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-30-26	Initiated	William Blair	Mkt Perform
Jul-15-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$9
Jul-10-25	Downgrade	Jefferies	Buy → Hold	$9
Jul-09-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$9
Jul-09-25	Downgrade	Oppenheimer	Outperform → Perform
Jul-09-25	Downgrade	BTIG Research	Buy → Neutral
May-19-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$25
Apr-15-25	Initiated	Piper Sandler	Neutral	$18
Apr-09-25	Downgrade	UBS	Buy → Neutral	$16
Apr-04-25	Downgrade	JP Morgan	Overweight → Underweight	$40 → $17
Apr-03-25	Downgrade	BofA Securities	Buy → Underperform	$36 → $22
Dec-20-24	Downgrade	Stifel	Buy → Hold	$65 → $40
Dec-11-24	Downgrade	Wells Fargo	Overweight → Equal Weight	$56 → $42
Dec-06-24	Initiated	UBS	Buy	$52
Oct-29-24	Initiated	Jefferies	Buy	$72
Aug-20-24	Reiterated	Needham	Buy	$54 → $66
Aug-06-24	Reiterated	Needham	Buy	$75 → $54
May-07-24	Reiterated	BTIG Research	Buy	$61 → $72
Dec-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$31 → $42
Dec-12-23	Initiated	Stifel	Buy	$40

Show Previous Ratings

Feb-11-26 04:10PM	RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 (GlobeNewswire)
03:15PM	RxSight, Inc. (RXST) Initiated at Market Perform as Firm Seeks Sales Reacceleration (Insider Monkey)
Jan-30-26 09:54AM	Spotify upgraded, Pinterest downgraded: Wall Street's top analyst calls (The Fly)
Jan-13-26 06:16AM	RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock? (Zacks)
Jan-11-26 09:30AM	RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer (GlobeNewswire)
04:05PM	Loading…
Jan-02-26 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-23-25 12:42PM	RxSight CFO exit raises concerns over pace of recovery, BTIG says (Investing.com) -9.98%
Dec-22-25 05:15PM	RxSight, Inc. Announces Chief Financial Officer Transition (GlobeNewswire)
Nov-20-25 04:05PM	RxSight, Inc. to Present at the Piper Sandler Healthcare Conference (GlobeNewswire) -5.79% +13.41%
Nov-06-25 12:04AM	RxSight Inc (RXST) Q3 2025 Earnings Call Highlights: Navigating Growth Amid Revenue Challenges (GuruFocus.com)
Nov-05-25 06:50PM	RxSight, Inc. (RXST) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.33%
04:05PM	RxSight, Inc. Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 08:31AM	RxSight Inc (RXST) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-22-25 04:05PM	RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire)
Oct-16-25 04:05PM	RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting (GlobeNewswire) +7.34%
08:45AM	Loading…
Sep-16-25 08:45AM	Investors in RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire)
Sep-15-25 09:32AM	RxSight (RXST) Fell Due to Missed Expectations and Guidance Reduction (Insider Monkey)
Sep-09-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire) +9.40%
Sep-05-25 04:09PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Sep-04-25 03:59PM	Investors Urged to Contact Levi & Korsinsky for Information Before September 22, 2025 - RxSight, Inc. (RXST) (Newsfile)
Aug-25-25 04:05PM	RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference (GlobeNewswire) -7.22%
Aug-22-25 08:45AM	RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST (PR Newswire) +6.30%
Aug-14-25 04:05PM	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-13-25 05:14PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile) +13.06%
Aug-12-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST (PR Newswire) +10.53%
Aug-07-25 06:15PM	RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates (Zacks) -7.70%
04:05PM	RxSight, Inc. Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 08:05AM	RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors (GlobeNewswire)
Aug-01-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire)
Jul-31-25 04:15PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
04:02PM	Loading…
Jul-30-25 04:02PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Jul-25-25 04:54PM	RxSight, Inc. (RXST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Jul-24-25 04:05PM	RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jul-09-25 03:00AM	RxSight Inc (RXST) Q2 2025 Earnings Call Highlights: Strategic Shifts Amid Market Challenges (GuruFocus.com) -37.84%
Jul-08-25 04:05PM	RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance (GlobeNewswire)
Jul-04-25 11:40AM	FMS vs. RXST: Which Stock Is the Better Value Option? (Zacks)
Jun-18-25 11:40AM	KMDA vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
11:40AM	FMS or RXST: Which Is the Better Value Stock Right Now? (Zacks)
May-31-25 05:59AM	Down Over 30%: Wells Fargo Says Now Is the Time to Load Up on These 2 Beaten-Down Stocks (TipRanks)
May-23-25 08:32AM	Do Options Traders Know Something About RxSight Stock We Don't? (Zacks)
May-20-25 04:10PM	RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum (GlobeNewswire)
10:55AM	Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued (Insider Monkey)
May-08-25 03:31AM	RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances Amid ... (GuruFocus.com) -11.21%
May-07-25 11:04PM	RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript (Seeking Alpha) +6.81%
07:55PM	RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-01-25 10:01AM	CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-30-25 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire)
10:01AM	RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-23-25 04:05PM	RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025 (GlobeNewswire)
Apr-04-25 11:46AM	JP Morgan downgrades RxSight on market, competitive pressures (Investing.com)
09:40AM	Block upgraded, Nvidia downgraded: Wall Streets top analyst calls (TipRanks)
03:00AM	RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ... (GuruFocus.com)
Apr-03-25 10:39PM	Preliminary Q1 2025 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) -37.94%
05:57PM	?RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade) (Seeking Alpha)
03:54PM	RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript) (Seeking Alpha)
12:59PM	RxSight Plunges 44% After Slashing 2025 Guidance; Bank of America Downgrades Stock (GuruFocus.com)
07:32AM	RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges (Benzinga)
Apr-02-25 08:00PM	RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance (GlobeNewswire)
Mar-28-25 03:59PM	Baird Q4 2024 Small/Mid Cap Growth Equity Commentary (Seeking Alpha)
Mar-25-25 04:05PM	RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-26-25 02:15AM	RxSight Inc (RXST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-25-25 05:55PM	RxSight, Inc. (RXST) Misses Q4 Earnings Estimates (Zacks)
04:05PM	RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance (GlobeNewswire)
01:36AM	What To Expect From RxSight Inc (RXST) Q4 2024 Earnings (GuruFocus.com)
Feb-11-25 04:10PM	RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025 (GlobeNewswire)
Jan-18-25 07:55AM	RxSight price target lowered to $43 from $66 at Needham (TipRanks)
Jan-12-25 09:30AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance (GlobeNewswire)
Jan-02-25 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-24 09:43AM	Do You Believe in the Long-Term Growth Potential of RxSight (RXST)? (Insider Monkey) -11.86%
Nov-20-24 12:00PM	RxSight (RXST) Upgraded to Buy: Here's What You Should Know (Zacks)
Nov-08-24 12:02PM	RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ... (GuruFocus.com) -5.59%
Nov-07-24 07:00PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q3 (Zacks) -7.09%
04:05PM	RxSight, Inc. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:16AM	What To Expect From RxSight Inc (RXST) Q3 2024 Earnings (GuruFocus.com) +5.80%
Oct-24-24 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 (GlobeNewswire)
Oct-15-24 06:10PM	RxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge Funds (Insider Monkey)
Oct-13-24 05:33PM	RxSight, Inc. (RXST): Top Investors Are Investing In This Small-Cap Stock Now (Insider Monkey)
Aug-22-24 04:05PM	RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences (GlobeNewswire)
Aug-19-24 03:43PM	RxSight Stock Sees Relative Strength Rating Rise To 91 (Investor's Business Daily)
Aug-12-24 09:55AM	Does RxSight (RXST) Have the Potential to Rally 27.64% as Wall Street Analysts Expect? (Zacks)
Aug-06-24 09:55AM	Q2 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +17.34%
Aug-05-24 06:10PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q2 (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
11:20AM	The 3 Best Med Tech Stocks to Buy Now (InvestorPlace)
Jul-29-24 09:35AM	Down -26.04% in 4 Weeks, Here's Why RxSight (RXST) Looks Ripe for a Turnaround (Zacks)
Jul-22-24 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 (GlobeNewswire)
Jul-12-24 09:35AM	RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jul-10-24 10:59AM	Dow Flat As Nasdaq, S&P 500 Rise Again; Gold Stocks Rally, But These Growth Players Get Hit (Live Coverage) (Investor's Business Daily) -10.32%
Jun-18-24 01:50AM	Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST) (GuruFocus.com)
Jun-13-24 11:22AM	Eye Care Innovator In Buy Zone; 176% Growth Expected For IBD 50 Stock (Investor's Business Daily)
Jun-07-24 02:40PM	These 5 Companies Lost Money. Here's Why They're Still On The IBD 50. (Investor's Business Daily)
Jun-05-24 04:05PM	RxSight, Inc. To Participate in the Truist Securities Medtech Conference (GlobeNewswire)
May-30-24 04:00AM	Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board (GlobeNewswire)
May-28-24 12:00PM	What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now? (Zacks)
May-24-24 11:40AM	Why Top-Rated Medtech RxSight Has 20/20 Vision And Is Seeing 50% Growth (Investor's Business Daily)
May-13-24 04:58PM	RxSight Raises $115 Million From Public Offering of Shares (MT Newswires)
04:05PM	RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
May-08-24 09:15PM	RxSight, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:05PM	RxSight, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Goldshleger Ilya	See remarks	Sep 25 '25	Option Exercise	4.27	23,445	99,998	65,691	Sep 26 04:07 PM
Weinberg Eric	See remarks	Jun 02 '25	Option Exercise	3.93	188,002	738,848	195,351	Jun 03 06:18 PM
Thunen Shelley B	See remarks	Apr 14 '25	Option Exercise	4.34	7,792	33,806	38,354	Apr 15 08:57 PM
Fountain Tamara	Director	Mar 12 '25	Sale	25.71	7,000	180,002	24,793	Mar 13 04:46 PM
TAMARA R FOUNTAIN	Director	Mar 12 '25	Proposed Sale	25.71	7,000	180,002		Mar 12 04:02 PM

COO Cooper Companies, Inc daily Stock Chart

Peers: ALGN SYK JNJ ISRG BSX ZBH MDT BAX HOLX STE

| Held by: VTI VOO VB VBR IVV SPY RSP XLV IWR VHT

Index	S&P 500	P/E	44.29	EPS (ttm)	1.87	Insider Own	0.68%	Shs Outstand	195.90M	Perf Week	1.08%
Market Cap	16.26B	Forward P/E	16.75	EPS next Y	4.96	Insider Trans	2.62%	Shs Float	194.64M	Perf Month	1.59%
Enterprise Value	18.94B	PEG	1.69	EPS next Q	1.03	Inst Own	109.25%	Short Float	4.18%	Perf Quarter	14.48%
Income	374.90M	P/S	3.97	EPS this Y	9.73%	Inst Trans	2.78%	Short Ratio	3.06	Perf Half Y	13.00%
Sales	4.09B	P/B	1.97	EPS next Y	9.61%	ROA	3.03%	Short Interest	8.13M	Perf YTD	1.26%
Book/sh	42.06	P/C	147.05	EPS next 5Y	9.90%	ROE	4.59%	52W High	94.17 -11.87%	Perf Year	-11.41%
Cash/sh	0.56	P/FCF	37.50	EPS past 3/5Y	-1.15% 9.30%	ROIC	3.43%	52W Low	61.78 34.34%	Perf 3Y	-1.90%
Dividend Est.	-	EV/EBITDA	17.86	Sales past 3/5Y	7.35% 10.98%	Gross Margin	60.67%	Volatility	2.50% 2.15%	Perf 5Y	-13.87%
Dividend TTM	-	EV/Sales	4.63	EPS Y/Y TTM	-4.47%	Oper. Margin	16.69%	ATR (14)	1.95	Perf 10Y	148.51%
Dividend Ex-Date	Jul 26, 2023	Quick Ratio	1.13	Sales Y/Y TTM	5.06%	Profit Margin	9.16%	RSI (14)	56.28	Recom	2.14
Dividend Gr. 3/5Y	- -	Current Ratio	1.89	EPS Q/Q	-26.90%	SMA20	2.00%	Beta	1.02	Target Price	90.56
Payout	0.00%	Debt/Eq	0.34	Sales Q/Q	4.60%	SMA50	1.71%	Rel Volume	0.82	Prev Close	81.70
Employees	15000	LT Debt/Eq	0.33	Earnings	Mar 05 AMC	SMA200	10.99%	Avg Volume	2.66M	Price	82.99
IPO	Jan 21, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.30% 0.42%	Trades		Volume	2,176,416	Change	1.58%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-03-26	Reiterated	Needham	Buy	$100 → $99
Nov-13-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$72
Oct-13-25	Initiated	Barclays	Overweight	$85
Oct-01-25	Initiated	Goldman	Sell	$64
Aug-28-25	Downgrade	Citigroup	Buy → Neutral	$72
Jul-22-25	Upgrade	BNP Paribas Exane	Neutral → Outperform	$92
Jun-17-25	Upgrade	Needham	Hold → Buy	$94
May-30-25	Downgrade	JP Morgan	Overweight → Neutral	$76
Aug-29-24	Reiterated	Piper Sandler	Overweight	$115 → $120
Jul-16-24	Upgrade	Jefferies	Hold → Buy	$107 → $115
Mar-19-24	Upgrade	Redburn Atlantic	Neutral → Buy	$125
Mar-13-24	Upgrade	JP Morgan	Neutral → Overweight	$100 → $120
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-30-23	Initiated	BofA Securities	Buy	$380
Oct-05-23	Downgrade	Redburn Atlantic	Overweight → Neutral	$390 → $343
May-30-23	Initiated	Morgan Stanley	Equal-Weight	$410
Dec-22-22	Initiated	Mizuho	Buy	$375
Nov-30-22	Upgrade	Robert W. Baird	Neutral → Outperform	$345 → $375
Oct-12-22	Downgrade	Jefferies	Buy → Hold	$400 → $295
Aug-29-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight

Show Previous Ratings

Feb-13-26 11:40AM	COO vs. WST: Which Stock Is the Better Value Option? (Zacks)
Feb-11-26 01:34PM	BD Merges Biosciences & Diagnostics Business With Waters (Zacks)
Feb-10-26 09:23AM	The Cooper Companies (COO) Moved Higher as Multiple Tailwinds Align (Insider Monkey)
Feb-05-26 04:15PM	CooperCompanies Announces Release Date for First Quarter 2026 (GlobeNewswire)
Feb-04-26 05:20PM	Align Technology (ALGN) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
01:17PM	Loading…
Feb-03-26 01:17PM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
12:10PM	Will The Cooper Companies (COO) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:05AM	Diamond Hill Large Cap Fund Purchased Cooper Companies (COO) Betting on the Resilient Contact Lens Industry (Insider Monkey)
Feb-02-26 11:57AM	BD & Envetec Showcase Closed-Loop Recycling Solution for Lab Plastics (Zacks)
Jan-29-26 11:38PM	1 Healthcare Stock to Own for Decades and 2 We Question (StockStory)
12:17PM	CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up (Zacks)
Jan-28-26 11:40AM	COO vs. WST: Which Stock Should Value Investors Buy Now? (Zacks)
Jan-27-26 12:19PM	Here's Why You Should Add Merit Medical Stock to Your Portfolio Now (Zacks)
09:45AM	Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term (Zacks)
Jan-26-26 09:40AM	Here's Why The Cooper Companies (COO) is a Strong Value Stock (Zacks)
01:50PM	Loading…
Jan-23-26 01:50PM	WST Launches Synchrony S1 Prefillable Syringe at Pharmapack (Zacks)
07:57AM	What You Need to Know Ahead of The Cooper Companies' Earnings Release (Barchart)
Jan-22-26 11:08AM	Here's Why You Should Retain Integer Holdings Stock in Your Portfolio (Zacks)
10:43AM	BD and Ypsomed Expand Partnership to Target Growing Biologics Market (Zacks)
Jan-21-26 11:43AM	BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System (Zacks)
Jan-14-26 12:50PM	Reasons to Add West Pharmaceutical Stock to Your Portfolio Now (Zacks)
Jan-13-26 11:16AM	Judge Denies Teva Bid To Pause Paragard Copper Contraceptive Device Lawsuit Trial (Benzinga)
Jan-12-26 11:40AM	COO or WST: Which Is the Better Value Stock Right Now? (Zacks)
Jan-07-26 03:00PM	40 stocks likely to outperform in 2026: Boyar pres. explains (Yahoo Finance Video)
Jan-06-26 08:00AM	CooperVision to Launch MyDay MiSight 1 day Myopia Control Soft Contact Lenses (PR Newswire)
Jan-05-26 07:17AM	Hologic Trading Near 52-Week High: How Should You Play the Stock? (Zacks)
Jan-01-26 10:32PM	Medical Devices & Supplies - Diversified Stocks Q3 In Review: CooperCompanies (NASDAQ:COO) Vs Peers (StockStory)
Dec-31-25 07:36AM	What Makes The Cooper Companies (COO) an Investment Bet? (Insider Monkey)
Dec-30-25 02:04PM	Top Stock Reports for Berkshire Hathaway, AstraZeneca & Intel (Zacks)
07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
04:15PM	Loading…
Dec-29-25 04:15PM	CooperCompanies to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-26-25 11:40AM	COO vs. MMSI: Which Stock Is the Better Value Option? (Zacks)
Dec-23-25 08:00AM	CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors (GlobeNewswire)
Dec-22-25 12:12PM	BD and Penn Institute Ink Collaboration to Advance Immunotherapy (Zacks)
Dec-19-25 09:55AM	The Cooper Companies (COO)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
Dec-16-25 11:05PM	3 Reasons to Sell COO and 1 Stock to Buy Instead (StockStory)
11:37AM	BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe (Zacks)
Dec-12-25 09:50AM	Why The Cooper Companies (COO) is a Top Momentum Stock for the Long-Term (Zacks)
Dec-11-25 07:34AM	Is The Cooper Companies Stock Underperforming the Nasdaq? (Barchart)
12:31AM	5 Insightful Analyst Questions From CooperCompanies's Q3 Earnings Call (StockStory)
Dec-10-25 11:40AM	COO or MMSI: Which Is the Better Value Stock Right Now? (Zacks)
Dec-08-25 09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
09:15AM	The Cooper Companies (COO) International Revenue Performance Explored (Zacks)
Dec-05-25 11:11AM	CooperCompanies (COO) Stock Trades Up, Here Is Why (StockStory) +5.67%
11:02AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
09:11AM	COO Gains as Q4 Earnings & Sales Beat Estimates, MyDay Adoption Rises (Zacks)
07:36AM	Warner Bros. shares rise on Netflix deal news, Hewlett Packard Enterprise slumps on earnings and more early market movers (MarketWatch)
02:46AM	Stock Market Today: Dow, S&P 500 and Nasdaq point to gains as investors await Fed's preferred inflation gauge; bitcoin slips, silver surges (MarketWatch)
12:31AM	COO Q3 Deep Dive: Product Momentum and Strategic Review Shape Outlook (StockStory)
12:02AM	The Cooper Companies Inc (COO) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Dec-04-25 06:30PM	The Cooper Companies (COO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	The Cooper Companies (COO) Q4 Earnings and Revenues Surpass Estimates (Zacks)
04:45PM	CooperCompanies (NASDAQ:COO) Reports Q3 CY2025 In Line With Expectations, Stock Soars (StockStory)
04:20PM	CooperCompanies Announces New Chair of the Board and Strategic Review (GlobeNewswire)
04:15PM	CooperCompanies Announces Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Dec-03-25 05:15PM	HealthEquity (HQY) Tops Q3 Earnings and Revenue Estimates (Zacks)
12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Dec-02-25 10:04PM	What To Expect From CooperCompanies's (COO) Q3 Earnings (StockStory)
Dec-01-25 09:15AM	Curious about The Cooper Companies (COO) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
06:11AM	1 Profitable Stock to Own for Decades and 2 We Find Risky (StockStory)
Nov-30-25 07:27AM	Stocks drift back towards record highs as the final month of 2025 gets underway: What to watch this week (Yahoo Finance)
07:27AM	Stocks drift back toward record highs as the final month of 2025 gets underway: What to watch this week (Yahoo Finance)
Nov-27-25 10:00AM	The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy? (Zacks)
Nov-23-25 11:36PM	1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds (StockStory)
Nov-21-25 06:36PM	CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know (StockStory) +6.13%
Nov-19-25 06:38AM	Cooper Companies Stock: Analyst Estimates & Ratings (Barchart)
Nov-14-25 05:10PM	Jana Partners' Strategic Move: Significant Addition of The Cooper Companies Inc (GuruFocus.com)
Nov-13-25 05:20PM	Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
09:45AM	Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls (The Fly)
09:10AM	Here Are Thursdays Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More (24/7 Wall St.)
Nov-06-25 07:40AM	Becton Dickinson (BDX) Tops Q4 Earnings and Revenue Estimates (Zacks)
Nov-05-25 06:30PM	Conmed (CNMD) Tops Q3 Earnings and Revenue Estimates (Zacks)
Nov-04-25 04:15PM	CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025 (GlobeNewswire)
Nov-03-25 12:00PM	Can Sustained Product Demand Drive BDX Stock Before Q4 Earnings? (Zacks)
Oct-31-25 10:23AM	4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks (Zacks)
Oct-28-25 01:54AM	What to Expect From Cooper Companies Next Quarterly Earnings Report (Barchart)
Oct-21-25 09:24AM	Company News for Oct 21, 2025 (Zacks)
Oct-20-25 09:34AM	Stocks to Watch Monday: Amazon, Zions Bancorp, Kering (The Wall Street Journal)
08:21AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:41AM	Cooper Cos. Stock Rises as Report Says Activist Investor Takes Stake (Barrons.com)
07:25AM	Activist Jana Pushes Big Contact-Lens Combination of Cooper and Bausch + Lomb (The Wall Street Journal)
Oct-19-25 08:00PM	Activist Jana Takes Stake in Cooper, a Maker of Medical Devices (The Wall Street Journal)
Oct-16-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Oct-01-25 11:01AM	Goldman Sachs initiates ophthalmology coverage: Buy Glaukos, sell Cooper (Investing.com)
Sep-26-25 11:30AM	The Cooper Companies (COO) Up 3.6% Since Last Earnings Report: Can It Continue? (Zacks)
12:39AM	3 Healthcare Stocks That Fall Short (StockStory)
Sep-22-25 09:46AM	Reasons to Retain Cooper Companies Stock in Your Portfolio for Now (Zacks)
Sep-19-25 01:55AM	Is Cooper Companies Stock Underperforming the S&P 500? (Barchart)
Sep-18-25 11:42AM	Why CooperCompanies (COO) Stock Is Up Today (StockStory)
Sep-17-25 04:15PM	CooperCompanies Announces Expanded Share Repurchase Program (GlobeNewswire)
Sep-15-25 09:40AM	Here's Why The Cooper Companies (COO) is a Strong Value Stock (Zacks)
Sep-09-25 12:02AM	3 Reasons COO is Risky and 1 Stock to Buy Instead (StockStory)
Sep-03-25 01:31AM	5 Insightful Analyst Questions From CooperCompanies's Q2 Earnings Call (StockStory)
Sep-02-25 03:30PM	Why CooperCompanies (COO) Shares Are Falling Today (StockStory)
Sep-01-25 09:15AM	Interpreting The Cooper Companies (COO) International Revenue Trends (Zacks)
Aug-31-25 11:34PM	Medical Devices & Supplies - Diversified Stocks Q2 Recap: Benchmarking CooperCompanies (NASDAQ:COO) (StockStory)
Aug-29-25 09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
Aug-28-25 05:28PM	Why Cooper Companies Stock Sank by 13% Today (Motley Fool) -12.85%
04:25PM	These Stocks Moved the Most Today: Nvidia, Snowflake, Pure Storage, CrowdStrike, Hormel Foods, Cooper, HP, and More (Barrons.com)

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jay Colleen	Director	Jan 12 '26	Option Exercise	39.40	7,064	278,322	36,585	Jan 14 04:05 PM
White Albert G III	President & CEO	Jan 08 '26	Option Exercise	0.00	18,340	0	254,491	Jan 12 04:24 PM
Warner Gerard H III	President, CooperVision, Inc.	Jan 08 '26	Option Exercise	0.00	11,518	0	29,837	Jan 12 04:24 PM
Sheffield Holly R	President, CSI	Jan 08 '26	Option Exercise	0.00	8,050	0	47,102	Jan 12 04:23 PM
McBride Daniel G	EVP & Chief Operating Officer	Jan 08 '26	Option Exercise	0.00	12,887	0	76,007	Jan 12 04:23 PM
Andrews Brian G	EVP, CFO & Treasurer	Jan 08 '26	Option Exercise	0.00	3,528	0	10,430	Jan 12 04:22 PM
Lucchese Cynthia L	Director	Dec 22 '25	Buy	84.06	1,784	149,963	9,445	Dec 23 04:08 PM
Rivas Maria	Director	Dec 18 '25	Buy	82.13	1,000	82,130	11,141	Dec 19 04:18 PM
Kurzius Lawrence Erik	Director	Dec 17 '25	Buy	82.50	2,000	165,000	7,777	Dec 17 05:06 PM
Sheffield Holly R	President, CSI	Dec 16 '25	Buy	80.75	1,230	99,322	39,052	Dec 16 06:36 PM
White Albert G III	President & CEO	Dec 16 '25	Buy	80.80	10,000	808,000	236,151	Dec 16 06:36 PM
Kurzius Lawrence Erik	Director	Sep 29 '25	Buy	68.39	2,000	136,780	5,777	Sep 29 08:36 PM
White Albert G III	President & CEO	Sep 05 '25	Buy	68.39	10,000	683,900	226,151	Sep 05 05:10 PM
Warner Gerard H III	President, CooperVision, Inc.	Sep 05 '25	Buy	69.23	1,450	100,384	18,319	Sep 05 04:07 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 02 '25	Buy	65.04	3,000	195,120	63,120	Sep 02 05:17 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 02 '25	Buy	65.68	1,525	100,162	22,191	Sep 02 05:16 PM
KOZY WILLIAM A	Director	Apr 01 '25	Option Exercise	0.00	2,857	0	31,149	Apr 03 04:09 PM
WEISS ROBERT S	Director	Apr 01 '25	Option Exercise	0.00	2,993	0	288,945	Apr 03 04:09 PM
Rivas Maria	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	2,721	Apr 03 04:08 PM
MADDEN TERESA S	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	12,357	Apr 03 04:08 PM
Lucchese Cynthia L	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	7,661	Apr 03 04:07 PM
Kurzius Lawrence Erik	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	3,777	Apr 03 04:07 PM
Jay Colleen	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	29,521	Apr 03 04:06 PM
Ricupati Agostino	SVP & CAO	Apr 01 '25	Option Exercise	0.00	2,076	0	9,044	Apr 03 04:06 PM

Open in Screener

STAA

Staar Surgical Co

Feb 13 • 04:00PM ET

16.10

-0.39 -2.37 %

Healthcare • Medical Instruments & Supplies • USA • NASD

STAA Staar Surgical Co daily Stock Chart

Peers: JNJ ALGN ISRG MDT ABT NVS BSX EW EYE SYK

| Held by: IJR VTI IWM VB VXF VBK SPSM IWO VTWO SCHA

Index	RUT	P/E	-	EPS (ttm)	-1.96	Insider Own	0.85%	Shs Outstand	49.35M	Perf Week	-8.42%
Market Cap	800.85M	Forward P/E	38.32	EPS next Y	0.42	Insider Trans	457.45%	Shs Float	49.32M	Perf Month	-26.21%
Enterprise Value	647.31M	PEG	0.94	EPS next Q	0.18	Inst Own	108.63%	Short Float	8.12%	Perf Quarter	-37.72%
Income	-96.37M	P/S	3.47	EPS this Y	-89.53%	Inst Trans	-10.32%	Short Ratio	2.90	Perf Half Y	-43.65%
Sales	230.59M	P/B	2.25	EPS next Y	1767.11%	ROA	-19.39%	Short Interest	4.01M	Perf YTD	-30.27%
Book/sh	7.17	P/C	4.16	EPS next 5Y	40.96%	ROE	-24.65%	52W High	30.81 -47.74%	Perf Year	0.88%
Cash/sh	3.87	P/FCF	-	EPS past 3/5Y	- -	ROIC	-24.86%	52W Low	14.69 9.60%	Perf 3Y	-76.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	10.85% 15.89%	Gross Margin	72.18%	Volatility	4.09% 4.56%	Perf 5Y	-87.02%
Dividend TTM	-	EV/Sales	2.81	EPS Y/Y TTM	-540.37%	Oper. Margin	-28.42%	ATR (14)	0.87	Perf 10Y	156.37%
Dividend Ex-Date	-	Quick Ratio	4.35	Sales Y/Y TTM	-32.42%	Profit Margin	-41.79%	RSI (14)	20.71	Recom	3.18
Dividend Gr. 3/5Y	- -	Current Ratio	5.21	EPS Q/Q	-12.41%	SMA20	-12.90%	Beta	1.09	Target Price	23.53
Payout	-	Debt/Eq	0.11	Sales Q/Q	6.93%	SMA50	-25.50%	Rel Volume	0.58	Prev Close	16.49
Employees	1211	LT Debt/Eq	0.10	Earnings	Nov 05 AMC	SMA200	-28.80%	Avg Volume	1.38M	Price	16.10
IPO	Jul 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.16% 0.03%	Trades		Volume	805,650	Change	-2.37%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-03-26	Initiated	Wedbush	Neutral	$26
Jan-16-26	Resumed	Morgan Stanley	Underweight	$13
Apr-21-25	Initiated	Wells Fargo	Equal Weight	$17
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-12-25	Downgrade	Mizuho	Outperform → Neutral	$45 → $17
Feb-12-25	Downgrade	Jefferies	Buy → Hold
Feb-12-25	Downgrade	BTIG Research	Buy → Neutral
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$50 → $37
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy	$46
Mar-11-24	Upgrade	Stifel	Hold → Buy	$30 → $50
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$35
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold	$77 → $48
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral	$65
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy	$80 → $67
Dec-08-22	Initiated	Stifel	Hold	$60
Nov-07-22	Upgrade	Sidoti	Neutral → Buy

Show Previous Ratings

Feb-09-26 11:37PM	1 Cash-Heavy Stock on Our Watchlist and 2 We Brush Off (StockStory)
Feb-05-26 10:00AM	West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy? (Zacks)
07:55AM	Cardinal Health (CAH) Q2 Earnings and Revenues Surpass Estimates (Zacks)
Feb-04-26 01:27PM	STAAR Surgical Company (STAA): A Bull Case Theory (Insider Monkey)
Feb-03-26 10:00AM	Staar Surgical (STAA) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks)
09:34AM	Loading…
09:34AM	Adobe downgraded, Palantir upgraded: Wall Street's top analyst calls (The Fly)
05:23AM	STAAR names interim co-CEOs amid search for permanent leader (MedTech Dive)
Feb-02-26 12:55PM	Why STAAR Surgical (STAA) Stock Is Trading Lower Today (StockStory)
07:00AM	STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs (Business Wire)
Jan-30-26 01:00PM	Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems (Benzinga)
Jan-25-26 08:18PM	Analysts Question STAAR Surgical Company (STAA)'s Post-Merger Standalone Valuation (Insider Monkey)
Jan-23-26 04:35PM	Staar Surgical, Dynatrace, and More Stocks See Action From Activist Investors (Barrons.com)
Jan-16-26 08:39PM	Staar Surgical, Alumis, and More Stocks See Action From Activist Investors (Barrons.com)
09:32AM	Seagate upgraded, Tractor Supply downgraded: Wall Street's top analyst calls (The Fly)
08:02AM	Here Are Fridays Top Wall Street Analyst Research Calls: ConocoPhillips, Devon Energy, Garmin, Honeywell, HP, PepsiCo, Rocket Labs, Seagate, and More (24/7 Wall St.)
05:00AM	Loading…
05:00AM	STAAR CEO exits after company rejects Alcon buyout (MedTech Dive)
Jan-15-26 11:04PM	STAAR Surgical (STAA): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
01:06PM	STAAR Surgical Stock Falls After Largest Shareholder Broadwood Gains Board Influence (Benzinga)
08:30AM	STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement (Business Wire)
Jan-13-26 08:45AM	Mitsui Sumitomo Continues to Build WR Berkley Stake (24/7 Wall St.)
Jan-07-26 07:38AM	STAAR Surgical terminates Alcon merger agreement (Medical Device Network)
Jan-06-26 08:00PM	Alcon Terminates Agreement to Acquire STAAR Surgical (Business Wire) -6.91%
12:32PM	Health Care Roundup: Market Talk (The Wall Street Journal)
12:14PM	Exclusive: STAAR Surgical deal fails as shareholder support remains at around 30% (Investing.com)
09:52AM	Broadwood Partners Comments on STAAR Surgical Shareholders Rejection of the Companys Proposed Sale to Alcon (Business Wire)
08:47AM	STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders (Business Wire)
06:13AM	STAAR shareholders reject Alcons revised buyout offer (MedTech Dive)
Dec-19-25 03:51PM	Exclusive: STAAR merger with Alcon still fails to gain traction, only 30% vote for (Investing.com)
12:59PM	Broadwood Partners Denounces STAAR Surgical's Fourth Delay of the Shareholder Vote on the Company's Proposed Sale to Alcon (Business Wire)
11:45AM	Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders (Business Wire)
06:47PM	Loading…
Dec-17-25 06:47PM	Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day (Investing.com) -7.22%
04:53PM	Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc. (PR Newswire)
01:17PM	Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails (Business Wire)
10:55AM	STAAR Stockholders Have a Choice: Vote FOR Alcon's Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value (Business Wire)
Dec-16-25 03:58PM	ISS recommends STAAR Surgical deal, but warns shareholders have reason to object (Investing.com) +5.26%
01:32PM	Yunqi Capital Comments on Proxy Advisors' Updated Recommendations, Urges Shareholders to Continue to Back the Company's Standalone Trajectory (Business Wire)
09:12AM	Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction (Business Wire)
07:00AM	Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon (Business Wire)
Dec-15-25 06:35PM	Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote "FOR" Alcon Merger (Business Wire)
Dec-12-25 05:29PM	Battle for STAAR Surgical intensifies as Glass Lewis reiterates stance against (Investing.com)
08:40AM	Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation "AGAINST" STAAR Surgical Sale to Alcon (Business Wire)
Dec-11-25 08:06PM	STAAR Surgical accuses activist Broadwood of misinformation campaign (Investing.com)
11:41AM	Why STAAR Surgical (STAA) Stock Is Up Today (StockStory)
09:47AM	STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process (Business Wire)
07:00AM	Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon (Business Wire)
Dec-10-25 01:34PM	STAAR Surgical falls as Yunqi Capital reiterates opposition to merger with Alcon (Investing.com) -5.50%
07:05AM	Yunqi Capital Comments on STAAR Surgical's Go-Shop Process and Alcon's Revised Offer (Business Wire)
Dec-09-25 02:25PM	Alcon bumps STAAR Surgical bid to $30.75, but Broadwood remains vehemently against (Investing.com) +7.84%
02:16PM	STAAR Surgical (STAA) Shares Skyrocket, What You Need To Know (StockStory)
12:39PM	Broadwood Partners Responds to Alcon's Increase to Proposed Acquisition Price of STAAR Surgical (Business Wire)
12:00PM	What Makes Staar Surgical (STAA) a New Buy Stock (Zacks)
08:30AM	Alcon Announces Amended Merger Agreement with STAAR Surgical (Business Wire)
Dec-08-25 04:11PM	Why STAAR Surgical (STAA) Shares Are Plunging Today (StockStory) -7.25%
01:28PM	Broadwood Partners Reiterates Opposition to STAAR Surgical's Sale to Alcon Following Conclusion of Performative Go-Shop Process (Business Wire)
08:16AM	Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon (Business Wire)
08:00AM	STAAR Surgical Announces Expiration of Go-Shop Period (Business Wire)
Dec-04-25 10:35PM	STAAR Surgical (NASDAQ:STAA) Q3 Earnings: Leading The Medical Devices & Supplies - Specialty Pack (StockStory)
Dec-03-25 12:02PM	Broadwood reiterates push for STAAR Surgical board shake-up as Alcon vote nears (Investing.com)
Dec-02-25 04:14PM	Broadwood Partners Working to Call Special Meeting of STAAR Surgical Shareholders to Remove Three Directors (Business Wire)
Nov-26-25 03:34PM	Staar Surgical, Gold Royalty See Activist Action (Barrons.com)
Nov-18-25 04:15PM	STAAR Surgical reveals board dissent over amended Alcon deal ahead of vote (Investing.com)
Nov-12-25 02:35PM	Exclusive: Broadwood says Alcons earnings reveal STAAR bid came from weakness (Investing.com) -5.66%
Nov-10-25 06:38PM	Broadwood continues pressure on STAAR board, urges new directors amid go-shop move (Investing.com)
01:00PM	STAARs largest shareholder requests new directors in ongoing Alcon merger dispute (Medical Device Network)
08:00AM	Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process (Business Wire)
Nov-07-25 04:22PM	STAAR Surgical opens go-shop window amid shareholder revolt over Alcon deal (Investing.com)
10:10AM	STAAR Surgical Announces Amendments to Alcon Merger Agreement (Business Wire)
Nov-06-25 06:21AM	Yunqi Capital Applauds STAAR Surgicals Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated (Business Wire) +5.47%
Nov-05-25 04:27PM	Staar Surgical: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Third Quarter 2025 Results (Business Wire)
Nov-04-25 11:32PM	3 Stocks Under $50 We Keep Off Our Radar (StockStory)
03:13PM	Alcon, Broadwood trade blows in fight for STAAR Surgicals future (Investing.com)
11:52AM	Broadwood Partners Condemns Alcon's Fallacious Attacks on STAAR Surgical and Its Prospects (Business Wire)
01:00AM	Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders (Business Wire)
Oct-31-25 12:00PM	Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon (Business Wire)
11:14AM	Alcon rejects raised bid for STAAR Surgical as shareholders revolt (Investing.com)
Oct-27-25 04:43PM	Short Sellers Are Targeting Small-Caps. Megacaps Are Getting a Pass. (Barrons.com) +5.75%
08:00AM	STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon (Business Wire)
Oct-24-25 06:03PM	Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon (Business Wire)
01:59PM	Exclusive: Roughly 72% of STAAR Surgical shares oppose Alcon deal, vote delayed (Investing.com)
08:00AM	Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction (Business Wire)
Oct-23-25 12:09PM	Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders (Business Wire) +8.27%
Oct-22-25 02:35PM	Broadwood moves to oust STAAR Surgical directors over Alcon deal (Investing.com) -6.71%
06:17AM	Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors (Business Wire)
Oct-20-25 05:32PM	Yunqi Capital Issues Letter to STAAR Surgical's Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction (Business Wire) +5.41%
08:42AM	Broadwood Partners Highlights Growing Opposition to STAAR Surgicals Proposed Sale to Alcon (Business Wire)
07:30AM	STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025 (Business Wire)
Oct-17-25 08:00AM	Broadwood Partners Issues Letter to STAAR Surgical's Board Urging it to Allow Timely Shareholder Vote on Alcon Sale (Business Wire)
Oct-16-25 06:54PM	ISS recommendation may toll the bell for STAARAlcon deal, validates Broadwood (Investing.com) -5.97%
04:15PM	STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon (Business Wire)
Oct-15-25 01:36PM	Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon (Business Wire)
Oct-14-25 02:29PM	Broadwood Partners Comments on STAAR Surgical's Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon (Business Wire)
Oct-12-25 08:02PM	Broadwood slams STAAR board over carelessness in Alcon sale defense (Investing.com)
Oct-10-25 01:11PM	Broadwood Partners Issues Letter to STAAR Surgical's Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale (Business Wire)
Oct-09-25 09:28AM	Glass Lewis recommends against STAARAlcon merger, bolstering Broadwoods campaign (Investing.com)
Oct-08-25 11:40AM	STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote "FOR" the Alcon Merger Agreement on WHITE Proxy Card (Business Wire)
11:16AM	Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote AGAINST Sale to Alcon (Business Wire)
08:00AM	Broadwood Partners Questions Integrity of STAAR Surgical's Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon (Business Wire)
Oct-07-25 11:25AM	Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon (PR Newswire)
Oct-06-25 04:01PM	Yunqi Capital, One of STAAR Surgical Company's Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon (Business Wire)

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jiang Wei	Director	Jan 12 '26	Option Exercise	0.00	20,967	0	66,444	Jan 14 05:48 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 09 '26	Buy	22.05	27,485	606,138	15,453,629	Jan 13 09:30 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 06 '26	Buy	21.62	336,946	7,284,281	15,356,437	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 07 '26	Buy	22.00	66,467	1,462,301	15,422,904	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 08 '26	Buy	21.94	3,240	71,082	15,426,144	Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 21 '25	Buy	27.86	797,486	22,218,837	15,019,491	Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 20 '25	Buy	27.14	393,382	10,675,325	14,222,005	Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 19 '25	Buy	26.42	309,132	8,166,155	13,828,623	Nov 21 09:55 PM
Jiang Wei	Director	Nov 12 '25	Option Exercise	0.00	20,967	0	45,477	Nov 14 06:00 PM
Jiang Wei	Director	Aug 12 '25	Option Exercise	0.00	20,967	0	24,510	Aug 13 06:39 PM
WEISNER AIMEE S	Former Director	Aug 05 '25	Proposed Sale	26.87	1,750	47,025		Aug 05 06:38 PM
WEISNER AIMEE S	Former Director	Aug 05 '25	Proposed Sale	26.87	13,491	362,523		Aug 05 06:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 08 '25	Buy	15.32	178,127	2,729,095	13,510,391	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 09 '25	Buy	15.08	8,200	123,676	13,518,591	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 10 '25	Buy	15.18	900	13,658	13,519,491	Apr 10 07:00 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 04 '25	Buy	15.91	497,631	7,917,191	13,194,210	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 03 '25	Buy	16.97	209,535	3,555,138	12,696,579	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 07 '25	Buy	15.61	138,054	2,155,174	13,332,264	Apr 07 08:28 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Apr 02 '25	Buy	17.43	31,780	553,925	12,487,044	Apr 02 08:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 31 '25	Buy	17.46	22,189	387,360	12,455,264	Apr 02 08:33 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 26 '25	Buy	17.50	101,633	1,778,517	12,421,324	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 28 '25	Buy	17.47	8,131	142,014	12,433,075	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 27 '25	Buy	17.48	3,620	63,294	12,424,944	Mar 28 06:45 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 21 '25	Buy	17.74	102,400	1,816,545	12,285,395	Mar 25 07:02 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 25 '25	Buy	17.44	34,296	598,177	12,319,691	Mar 25 07:02 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 20 '25	Buy	17.96	108,720	1,952,992	12,182,995	Mar 20 07:51 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 18 '25	Buy	17.54	93,124	1,633,291	12,074,275	Mar 20 07:51 PM
Foust Warren	Chief Operating Officer	Mar 12 '25	Option Exercise	0.00	8,175	0	26,088	Mar 14 07:24 PM
Michna Magda	Chief Clinical, Regulatory,	Mar 12 '25	Option Exercise	0.00	6,177	0	18,554	Mar 14 07:21 PM
SISITSKY NATHANIEL	General Counsel	Mar 12 '25	Option Exercise	0.00	5,827	0	27,762	Mar 14 07:20 PM
Williams Patrick F.	Chief Financial Officer	Mar 12 '25	Option Exercise	0.00	8,153	0	56,242	Mar 14 07:19 PM
Williams Patrick F.	Chief Financial Officer	Mar 10 '25	Option Exercise	0.00	4,061	0	48,089	Mar 11 08:40 PM
Williams Patrick F.	Chief Financial Officer	Mar 07 '25	Option Exercise	0.00	5,689	0	44,028	Mar 11 08:40 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 04 '25	Buy	17.24	27,953	481,849	11,981,151	Mar 06 07:07 PM
FARRELL STEPHEN C	President & CEO	Mar 05 '25	Option Exercise	6.95	20,000	138,900	35,156	Mar 06 05:47 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 27 '25	Buy	17.05	259,316	4,420,106	11,548,753	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Mar 03 '25	Buy	16.64	249,503	4,151,214	11,953,198	Mar 03 07:12 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Feb 28 '25	Buy	17.45	154,942	2,704,235	11,703,695	Mar 03 07:12 PM

Open in Screener

WRBY

Warby Parker Inc

Feb 13 • 04:00PM ET

22.46

+1.09 5.10 %

Healthcare • Medical Instruments & Supplies • USA • NYSE

Peers: AMZN TGT WMT COST BBY DG DLTR M KSS JWN

| Held by: VTI IWM VB VBK VXF IWO JTEK VTWO SCHA SAMT

Index	RUT	P/E	5910.53	EPS (ttm)	0.00	Insider Own	18.56%	Shs Outstand	105.60M	Perf Week	-11.99%
Market Cap	2.74B	Forward P/E	45.35	EPS next Y	0.50	Insider Trans	-4.80%	Shs Float	99.49M	Perf Month	-21.99%
Enterprise Value	2.70B	PEG	1.61	EPS next Q	0.05	Inst Own	82.44%	Short Float	11.43%	Perf Quarter	28.42%
Income	0.72M	P/S	3.23	EPS this Y	20.05%	Inst Trans	6.22%	Short Ratio	2.75	Perf Half Y	-16.35%
Sales	850.58M	P/B	7.42	EPS next Y	34.40%	ROA	0.11%	Short Interest	11.37M	Perf YTD	3.07%
Book/sh	3.03	P/C	9.79	EPS next 5Y	28.20%	ROE	0.20%	52W High	31.00 -27.55%	Perf Year	-14.96%
Cash/sh	2.29	P/FCF	72.61	EPS past 3/5Y	50.37% 19.99%	ROIC	0.13%	52W Low	13.63 64.78%	Perf 3Y	51.86%
Dividend Est.	-	EV/EBITDA	60.46	Sales past 3/5Y	12.56% 15.80%	Gross Margin	52.37%	Volatility	8.76% 6.61%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.17	EPS Y/Y TTM	101.94%	Oper. Margin	-0.87%	ATR (14)	1.75	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.23	Sales Y/Y TTM	14.55%	Profit Margin	0.08%	RSI (14)	41.09	Recom	1.79
Dividend Gr. 3/5Y	- -	Current Ratio	2.58	EPS Q/Q	238.87%	SMA20	-11.44%	Beta	2.09	Target Price	27.83
Payout	-	Debt/Eq	0.63	Sales Q/Q	15.19%	SMA50	-11.33%	Rel Volume	0.60	Prev Close	21.37
Employees	3780	LT Debt/Eq	0.55	Earnings	Feb 26 BMO	SMA200	-2.81%	Avg Volume	4.13M	Price	22.46
IPO	Sep 29, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	31.57% -1.07%	Trades		Volume	2,486,306	Change	5.10%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$30
Nov-07-25	Reiterated	Telsey Advisory Group	Outperform	$28 → $24
Aug-01-25	Reiterated	Telsey Advisory Group	Outperform	$22 → $28
Jul-10-25	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Apr-30-25	Upgrade	Citigroup	Sell → Neutral	$17
Apr-17-25	Upgrade	Loop Capital	Hold → Buy	$27
Feb-28-25	Reiterated	Telsey Advisory Group	Outperform	$28 → $30
Feb-25-25	Initiated	ROTH MKM	Neutral	$26
Feb-05-25	Downgrade	Citigroup	Neutral → Sell	$19 → $23
Jan-17-25	Downgrade	Evercore ISI	Outperform → In-line	$23
Nov-19-24	Reiterated	Telsey Advisory Group	Outperform	$22 → $26
Nov-08-24	Reiterated	Telsey Advisory Group	Outperform	$19 → $22
Nov-07-24	Upgrade	William Blair	Mkt Perform → Outperform
Oct-21-24	Upgrade	Goldman	Neutral → Buy	$15 → $18
Aug-23-24	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$20
Aug-23-24	Resumed	Piper Sandler	Overweight	$18
Oct-12-23	Upgrade	BTIG Research	Neutral → Buy	$17
Oct-03-23	Upgrade	Evercore ISI	In-line → Outperform	$20
Sep-25-23	Initiated	UBS	Neutral	$13
Jun-27-23	Initiated	William Blair	Mkt Perform

Show Previous Ratings

Feb-13-26 03:50PM	Warby Parker and Bath and Body Works Shares Skyrocket, What You Need To Know (StockStory) +5.10%
Feb-12-26 07:00AM	Warby Parker to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (Business Wire)
Feb-10-26 08:49AM	Warby Parker taps Macys vet as CFO (Retail Dive) -6.79%
Feb-09-26 04:10PM	Warby Parker Appoints Adrian Mitchell as Chief Financial Officer (Business Wire) -5.41%
Feb-03-26 08:55PM	Warby Parker Inc. (WRBY): A Bull Case Theory (Insider Monkey)
05:35PM	Loading…
05:35PM	Clorox (CLX) Misses Q2 Earnings Estimates (Zacks)
Jan-30-26 05:52AM	Big Tech thinks smart glasses will be the first major piece of AI hardware (Yahoo Finance) -5.03%
Jan-28-26 03:01PM	Why Warby Parker (WRBY) Shares Are Plunging Today (StockStory) -7.04%
09:02AM	Snap seeks investments as new smart glasses unit takes on Meta (Reuters)
09:02AM	Snap doubles down on smart glasses with new independent unit (Reuters)
Jan-25-26 10:32PM	Q3 Earnings Highlights: Warby Parker (NYSE:WRBY) Vs The Rest Of The Beauty and Cosmetics Retailer Stocks (StockStory)
Jan-23-26 07:36AM	Riverwater Partners Small Cap Strategy's Investment Thesis for Warby Parker (WRBY) (Insider Monkey)
Jan-14-26 07:09AM	Warby Parker (WRBY) Soars 9.4% on Strong AI Glasses Demand (Insider Monkey)
Jan-13-26 11:05PM	3 Big Reasons to Love Warby Parker (WRBY) (StockStory) +9.44%
Jan-12-26 01:30PM	Why Warby Parker (WRBY) Shares Are Getting Obliterated Today (StockStory) -6.08%
07:31PM	Loading…
Jan-06-26 07:31PM	Warby Parker (WRBY) Soars 11% on PT Hike, AI Glasses Optimism (Insider Monkey) +11.57%
12:29PM	Meta Delays International Rollout for Ray-Ban Display Glasses (Barrons.com)
12:29PM	Meta Delays International Rollout for Ray-Ban Display Glasses Amid Strong Demand (Barrons.com)
Jan-05-26 12:15PM	Why Warby Parker (WRBY) Stock Is Trading Up Today (StockStory)
Jan-02-26 01:46PM	Warby Parker (WRBY) Stock Is Up, What You Need To Know (StockStory)
Dec-23-25 11:48AM	Marissa Mayers new startup Dazzle raises $8M led by Forerunners Kirsten Green (TechCrunch)
Dec-17-25 01:01PM	Warby Parker (WRBY) Stock Trades Up, Here Is Why (StockStory)
Dec-15-25 10:45AM	Google Is Planning to Launch AI Glasses in 2026. This 1 Stock to Buy Could Be the Biggest Winner. (Barchart)
Dec-14-25 02:41PM	Warby Parker (WRBY) Climbs 46% Ahead of 2026 AI Development (Insider Monkey)
Dec-13-25 07:00AM	4 Signs Your Startup Is Fundable, According To Top Investors (Black Enterprise)
Dec-11-25 10:19AM	Warby Parker (WRBY) Nears 4-Month High on Looming AI Glass Launch (Insider Monkey)
Dec-10-25 02:09PM	Is Google Stock a Buy Ahead of Its First AI Glasses Launch? (Barchart) +27.35%
10:35AM	EchoStar, Warby Parker, Cracker Barrel: Top Analyst Calls (Yahoo Finance Video)
Dec-09-25 04:54PM	Biggest Market Movers Today, Dec. 9: WRBY, DYN, & More (Motley Fool) +9.22%
02:22PM	Warby Parker (WRBY) Soars 13% Ahead of AI Glasses Launch (Insider Monkey)
02:16PM	Loading…
02:16PM	Why Warby Parker (WRBY) Stock Is Up Today (StockStory)
11:14AM	Ray-Ban Meta glasses take off but face privacy and competition test (Reuters)
11:00AM	4 signs your startup is fundable, according to top investors (Stacker)
Dec-08-25 07:26PM	Why Warby Parker Stock Was a Winner Today (Motley Fool) +13.27%
Nov-26-25 07:00AM	Warby Parker Announces Participation in the Morgan Stanley Global Consumer & Retail Conference (Business Wire)
Nov-18-25 01:21PM	Tales of Unexpected Losses: AXON, TREX, WRBY (Motley Fool)
Nov-13-25 12:32AM	Warby Parker's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Nov-12-25 10:38AM	Simon Unveils Rewards-stacked Loyalty Program (WWD)
Nov-07-25 09:41AM	WRBY Q3 Deep Dive: Revenue Miss and Guidance Reduction Amid Changing Consumer Trends (StockStory)
09:30AM	Warby Parker (WRBY) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
Nov-06-25 02:09PM	Warby Parker Inc (WRBY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) -11.13%
01:56PM	Warby Parker (WRBY) Stock Trades Down, Here Is Why (StockStory)
12:16PM	Why Warby Parker Stock Is Plummeting Today (Motley Fool)
07:55AM	Warby Parker Inc. (WRBY) Q3 Earnings Top Estimates (Zacks)
07:15AM	Warby Parker (NYSE:WRBY) Misses Q3 Sales Expectations, Stock Drops (StockStory)
06:45AM	Warby Parker Announces Third Quarter 2025 Results (Business Wire)
Nov-05-25 07:31AM	Warby Parker Inc (WRBY) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-04-25 10:09PM	Warby Parker (WRBY) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-31-25 03:21PM	Warby Parker (WRBY) Stock Is Up, What You Need To Know (StockStory)
Oct-16-25 07:00AM	Warby Parker to Announce Third Quarter 2025 Financial Results November 6, 2025 (Business Wire)
Oct-08-25 12:02AM	2 Reasons to Watch WRBY and 1 to Stay Cautious (StockStory)
Oct-07-25 11:36PM	Winners And Losers Of Q2: Warby Parker (NYSE:WRBY) Vs The Rest Of The Beauty and Cosmetics Retailer Stocks (StockStory)
Oct-05-25 03:53PM	What's a Supernova Stock? 3 Ideas for Your Watch List. (Motley Fool)
Sep-23-25 05:35AM	Warby Parkers Neil Blumenthal on whats next for the brand (Retail Dive)
Sep-22-25 10:22AM	The Motley Fool Interviews Dave Gilboa, Co-Founder and Co-CEO of Warby Parker (Motley Fool)
Sep-16-25 10:43AM	Meta Stock Rises. This Is Its New AI Product. (Barrons.com)
Sep-11-25 09:00AM	Warby Parker (WRBY) Rose Following the Partnership Announcement with Google (Insider Monkey)
Sep-05-25 04:23PM	Time to Buy? (Motley Fool)
Aug-28-25 04:05PM	Warby Parker Announces Participation in the Goldman Sachs 32nd Annual Global Retailing Conference (Business Wire)
Aug-27-25 10:27PM	Eyewear giant Warby Parker has a huge new sports partnership (TheStreet)
09:00AM	Warby Parker Teams Up with Arch Manning for Three-Year Partnership (Business Wire)
Aug-14-25 04:45PM	Warby Parker, Tilly's, Advance Auto Parts, RH, and Victoria's Secret Shares Plummet, What You Need To Know (StockStory)
01:33AM	The 5 Most Interesting Analyst Questions From Warby Parker's Q2 Earnings Call (StockStory)
Aug-13-25 12:05PM	Drivepoint Adds $9M From Top Tech And Consumer Investors To Accelerate AI Finance Platform For Retail Brands (PR Newswire) +9.83%
11:24AM	Direct-to-consumer IPOs go from boom to bust (Financial Times)
Aug-12-25 09:58AM	2 Stocks Under $50 Worth Your Attention and 1 Facing Challenges (StockStory) +5.12%
03:22AM	WRBY Q2 Deep Dive: Retail Expansion, AI Partnerships, and Margin Leverage Define the Quarter (StockStory)
Aug-11-25 04:45AM	Tariffs Test Warby Parkers Affordable Glasses Strategy (The Wall Street Journal)
Aug-10-25 05:30AM	How Warby Parker Has Kept the Price of Glasses at $95 for 15 Years (The Wall Street Journal)
Aug-07-25 02:32PM	Warby Parker's (NYSE:WRBY) Q2 Sales Top Estimates (StockStory)
09:30AM	Compared to Estimates, Warby Parker (WRBY) Q2 Earnings: A Look at Key Metrics (Zacks)
08:05AM	Warby Parker Inc. (WRBY) Q2 Earnings Match Estimates (Zacks)
07:27AM	Warby Parker to end home try-on program as it focuses on stores, digital experience (Retail Dive)
06:45AM	Warby Parker Announces Second Quarter 2025 Results (Business Wire)
Aug-06-25 07:10AM	National Vision (EYE) Beats Q2 Earnings and Revenue Estimates (Zacks)
Aug-05-25 11:02PM	What To Expect From Warby Parker's (WRBY) Q2 Earnings (StockStory)
Aug-01-25 01:56PM	Warby Parker, Petco, Tilly's, Abercrombie and Fitch, and RH Shares Plummet, What You Need To Know (StockStory)
07:15AM	Newell Brands (NWL) Q2 Earnings Match Estimates (Zacks)
Jul-31-25 05:25PM	Clorox (CLX) Q4 Earnings and Revenues Top Estimates (Zacks)
10:00AM	Warby Parker Inc. (WRBY) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-23-25 10:00AM	Nordstrom Rack to Open New Location in Mansfield, MA (PR Newswire)
Jul-17-25 06:05PM	Why Warby Parker (WRBY) Stock Is Trading Up Today (StockStory)
04:05PM	Warby Parker to Announce Second Quarter 2025 Financial Results August 7, 2025 (Business Wire)
Jul-09-25 10:31AM	Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. (Barrons.com)
08:25AM	Meta Wants to Reboot the Metaverse. Why AI Glasses Could Hold the Key. (Barrons.com)
Jul-08-25 03:13PM	Meta Invests $3.5 Billion in Worlds Largest Eye-Wear Maker in AI Glasses Push (Bloomberg)
Jul-07-25 11:32PM	Winners And Losers Of Q1: Warby Parker (NYSE:WRBY) Vs The Rest Of The Beauty and Cosmetics Retailer Stocks (StockStory)
02:33PM	Q&A: Warby Parker retail and experience chief talks store evolution, expansion (Chain Store Age)
Jul-04-25 05:30AM	American Companies Hit the Brakes on Hiring (The Wall Street Journal)
05:30AM	American Companies Had Lowest Job Growth in Eight Months (The Wall Street Journal)
Jun-30-25 08:29AM	What Makes Warby Parker (WRBY) an Attractive Investment? (Insider Monkey)
Jun-27-25 08:06AM	The 5 Most Interesting Analyst Questions From Warby Parker's Q1 Earnings Call (StockStory)
Jun-20-25 01:52PM	Meta and Oakley Are Launching AI-Powered Glasses This Summer (Investopedia)
Jun-19-25 12:05AM	Warby Parker (WRBY): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jun-18-25 09:30AM	Grifin Raises $11M Series A to Make Investing as Easy--And Automatic--as Everyday Spending (PR Newswire)
Jun-16-25 03:33PM	Warby Parkers Latest Vision (WWD)
Jun-13-25 10:02AM	RH Q1 Earnings Top Estimates, Revenues Miss, Margins Up Y/Y (Zacks)
Jun-09-25 10:32AM	Was Jim Cramer Right to Be Cautiously Bullish on Warby Parker (WRBY) Last Year? (Insider Monkey)
07:18AM	WRBY Q1 Earnings Call: Management Details Tariff Mitigation, Store Expansion, and Pricing Actions (StockStory)
Jun-02-25 07:00AM	Warby Parker Announces Participation in the Baird Global Consumer, Technology & Services Conference (Business Wire)

Warby Parker, Inc. is an online retailer of eyewear for men and women, which engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on May 7, 2010 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Blumenthal Neil Harris	Co-Chief Executive Officer	Jan 13 '26	Sale	29.99	660	19,793	37,119	Jan 15 06:36 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 13 '26	Sale	29.46	80,094	2,359,569	37,247	Jan 15 06:35 PM
DAVID GILBOA	Director	Jan 13 '26	Proposed Sale	26.58	80,094	2,128,899		Jan 13 04:22 PM
NEIL BLUMENTHAL	Director	Jan 13 '26	Proposed Sale	26.58	660	17,543		Jan 13 04:21 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 07 '26	Sale	27.09	75,000	2,031,750	37,247	Jan 09 08:48 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 09 '26	Sale	29.09	19,906	579,066	37,247	Jan 09 08:48 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jan 07 '26	Sale	27.08	50,000	1,354,000	37,119	Jan 09 08:47 PM
DAVID GILBOA	Director	Jan 09 '26	Proposed Sale	28.28	19,906	562,942		Jan 09 04:31 PM
NEIL BLUMENTHAL	Director	Jan 07 '26	Proposed Sale	25.94	50,000	1,297,000		Jan 07 04:25 PM
DAVID GILBOA	Director	Jan 07 '26	Proposed Sale	25.94	75,000	1,945,500		Jan 07 04:24 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jan 06 '26	Sale	25.09	150,000	3,763,500	37,119	Jan 06 08:55 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 06 '26	Sale	24.29	50,000	1,214,500	37,247	Jan 06 08:53 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jan 02 '26	Sale	22.46	25,000	561,500	37,247	Jan 06 08:53 PM
NEIL BLUMENTHAL	Director	Jan 06 '26	Proposed Sale	23.25	150,000	3,487,500		Jan 06 04:31 PM
DAVID GILBOA	Director	Jan 06 '26	Proposed Sale	23.25	50,000	1,162,500		Jan 06 04:28 PM
DAVID GILBOA	Director	Jan 02 '26	Proposed Sale	21.79	25,000	544,750		Jan 02 04:33 PM
Cutler Joel E	Director	Dec 16 '25	Sale	26.01	19,932	518,477	20,000	Dec 18 04:35 PM
Joel Cutler	Director	Dec 16 '25	Proposed Sale	26.65	32,249	859,436		Dec 16 06:13 PM
Moon Youngme E	Director	Dec 11 '25	Sale	29.07	38,832	1,128,846	27,057	Dec 15 05:30 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 11 '25	Sale	30.29	100,000	3,029,000	37,119	Dec 15 05:29 PM
Raider Jeffrey Jacob	Director	Dec 12 '25	Sale	27.42	25,000	685,500	483,485	Dec 15 05:28 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 11 '25	Sale	30.20	200,000	6,040,000	37,247	Dec 15 05:27 PM
Warby Parker Impact Foundation	10% Owner	Dec 15 '25	Proposed Sale	27.40	178,572	4,892,873		Dec 15 03:16 PM
JEFFREY RAIDER	Officer	Dec 12 '25	Proposed Sale	27.42	25,000	685,618		Dec 12 04:28 PM
David Gilboa	Director	Dec 11 '25	Proposed Sale	29.57	200,000	5,914,000		Dec 11 04:25 PM
NEIL BLUMENTHAL	Director	Dec 11 '25	Proposed Sale	29.57	100,000	2,957,000		Dec 11 04:24 PM
YOUNGME MOON	Director	Dec 11 '25	Proposed Sale	29.07	38,832	1,128,846		Dec 11 04:06 PM
Gilboa David Abraham	Co-Chief Executive Officer	Dec 02 '25	Option Exercise	0.00	9,816	0	42,677	Dec 04 05:03 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Dec 02 '25	Option Exercise	0.00	9,816	0	42,549	Dec 04 05:02 PM
Gilboa David Abraham	Co-Chief Executive Officer	Oct 01 '25	Sale	27.30	125,000	3,412,500	32,861	Oct 03 05:50 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 18 '25	Sale	27.58	58,360	1,609,569	32,861	Sep 19 05:42 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 17 '25	Sale	27.52	600	16,512	32,861	Sep 19 05:42 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 18 '25	Sale	27.52	8,416	231,608	32,733	Sep 19 05:40 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 17 '25	Sale	27.52	500	13,760	32,733	Sep 19 05:40 PM
David Gilboa	Director	Sep 18 '25	Proposed Sale	26.75	175,000	4,681,250		Sep 18 04:26 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 11 '25	Sale	27.53	41,040	1,129,831	32,861	Sep 15 05:17 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 11 '25	Sale	27.53	41,084	1,131,043	32,733	Sep 15 05:16 PM
NEIL BLUMENTHAL	Director	Sep 11 '25	Proposed Sale	27.01	50,000	1,350,500		Sep 11 04:31 PM
David Gilboa	Director	Sep 11 '25	Proposed Sale	27.01	50,000	1,350,500		Sep 11 04:31 PM
Cutler Joel E	Director	Sep 08 '25	Sale	26.75	35,000	936,352	19,932	Sep 10 08:53 PM
Joel Cutler	Director	Sep 08 '25	Proposed Sale	26.75	35,000	936,250		Sep 08 05:55 PM
Gilboa David Abraham	Co-Chief Executive Officer	Sep 03 '25	Option Exercise	0.00	9,815	0	38,290	Sep 05 05:15 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Sep 03 '25	Option Exercise	0.00	9,815	0	38,162	Sep 05 05:13 PM
Miller Steven Clive	Chief Financial Officer	Sep 03 '25	Option Exercise	0.00	28,475	0	248,875	Sep 05 05:12 PM
Briggs Teresa	Director	Aug 11 '25	Sale	23.56	6,000	141,360	44,879	Aug 13 08:22 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Aug 13 '25	Sale	25.11	50,000	1,255,500	28,347	Aug 13 08:19 PM
NEIL BLUMENTHAL	Director	Aug 13 '25	Proposed Sale	24.41	50,000	1,220,500		Aug 13 04:22 PM
Teresa Briggs	Director	Aug 11 '25	Proposed Sale	23.56	6,000	141,338		Aug 11 04:05 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jul 21 '25	Sale	24.21	49,600	1,200,816	28,347	Jul 22 06:00 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jul 18 '25	Sale	24.01	400	9,604	28,347	Jul 22 06:00 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jul 21 '25	Sale	24.27	74,500	1,808,115	28,475	Jul 22 05:58 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jul 18 '25	Sale	24.01	500	12,005	28,475	Jul 22 05:58 PM
David Gilboa	Director	Jul 18 '25	Proposed Sale	23.45	75,000	1,758,750		Jul 18 04:47 PM
NEIL BLUMENTHAL	Director	Jul 18 '25	Proposed Sale	23.45	50,000	1,172,500		Jul 18 04:47 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jul 01 '25	Sale	22.04	50,000	1,102,000	28,475	Jul 03 05:00 PM
David Gilboa	Director	Jul 01 '25	Proposed Sale	21.93	50,000	1,096,500		Jul 01 04:32 PM
Gilboa David Abraham	Co-Chief Executive Officer	Jun 03 '25	Option Exercise	0.00	9,816	0	33,905	Jun 05 08:23 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Jun 03 '25	Option Exercise	0.00	9,816	0	33,777	Jun 05 08:22 PM
Miller Steven Clive	Chief Financial Officer	Jun 03 '25	Option Exercise	0.00	30,175	0	237,092	Jun 05 08:21 PM
Moon Youngme E	Director	May 22 '25	Sale	19.90	33,073	658,153	53,869	May 27 05:13 PM
Moon Youngme E	Director	May 22 '25	Proposed Sale	19.90	33,073	658,153		May 22 04:29 PM
Miller Steven Clive	Chief Financial Officer	Mar 04 '25	Option Exercise	0.00	27,731	0	216,411	Mar 06 06:02 AM
Miller Steven Clive	Chief Financial Officer	Mar 04 '25	Sale	23.52	11,684	274,808	204,727	Mar 06 06:02 AM
Gilboa David Abraham	Co-Chief Executive Officer	Mar 04 '25	Option Exercise	0.00	3,271	0	52,057	Mar 05 09:57 PM
Gilboa David Abraham	Co-Chief Executive Officer	Mar 04 '25	Sale	23.51	202,968	4,772,513	24,089	Mar 05 09:57 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 04 '25	Option Exercise	0.00	3,271	0	51,928	Mar 05 09:56 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 03 '25	Sale	24.40	150,000	3,659,758	22,569	Mar 05 09:56 PM
Blumenthal Neil Harris	Co-Chief Executive Officer	Mar 04 '25	Sale	23.52	27,967	657,784	23,961	Mar 05 09:56 PM
Steven Clive Miller	Officer	Mar 04 '25	Proposed Sale	20.05	13,700	274,721		Mar 04 09:24 PM
David Abraham Gilboa	Director	Mar 04 '25	Proposed Sale	21.93	30,000	657,783		Mar 04 09:24 PM
Neil Harris Blumenthal	Director	Mar 04 '25	Proposed Sale	21.93	30,000	657,783		Mar 04 09:22 PM
NEIL BLUMENTHAL	Director	Mar 03 '25	Proposed Sale	24.73	50,000	1,236,500		Mar 03 05:00 PM

EYE National Vision Holdings Inc daily Stock Chart

Peers: AMZN WMT COST TGT CVS DG WBA DLTR VSTO FLWS

| Held by: IJR VTI IWM VB VBR VXF SPSM IJT IWN XSMO

Index	RUT	P/E	-	EPS (ttm)	-0.03	Insider Own	2.18%	Shs Outstand	79.26M	Perf Week	-2.42%
Market Cap	2.24B	Forward P/E	30.45	EPS next Y	0.93	Insider Trans	-7.98%	Shs Float	77.58M	Perf Month	-1.02%
Enterprise Value	2.88B	PEG	1.01	EPS next Q	0.06	Inst Own	120.11%	Short Float	12.29%	Perf Quarter	14.07%
Income	-2.31M	P/S	1.16	EPS this Y	34.66%	Inst Trans	9.33%	Short Ratio	7.23	Perf Half Y	22.96%
Sales	1.92B	P/B	2.60	EPS next Y	32.36%	ROA	-0.16%	Short Interest	9.54M	Perf YTD	9.30%
Book/sh	10.83	P/C	39.95	EPS next 5Y	30.22%	ROE	-0.37%	52W High	30.02 -6.00%	Perf Year	134.19%
Cash/sh	0.71	P/FCF	26.98	EPS past 3/5Y	- -	ROIC	-0.16%	52W Low	10.45 170.05%	Perf 3Y	-30.32%
Dividend Est.	-	EV/EBITDA	20.77	Sales past 3/5Y	-4.29% 1.12%	Gross Margin	53.98%	Volatility	4.33% 4.50%	Perf 5Y	-44.58%
Dividend TTM	-	EV/Sales	1.50	EPS Y/Y TTM	85.04%	Oper. Margin	2.50%	ATR (14)	1.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.32	Sales Y/Y TTM	-1.58%	Profit Margin	-0.12%	RSI (14)	55.52	Recom	1.58
Dividend Gr. 3/5Y	- -	Current Ratio	0.53	EPS Q/Q	138.53%	SMA20	3.28%	Beta	1.37	Target Price	33.18
Payout	-	Debt/Eq	0.81	Sales Q/Q	7.93%	SMA50	1.95%	Rel Volume	0.55	Prev Close	27.99
Employees	13411	LT Debt/Eq	0.67	Earnings	Nov 05 BMO	SMA200	14.39%	Avg Volume	1.32M	Price	28.22
IPO	Oct 26, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.15% 3.00%	Trades		Volume	721,278	Change	0.82%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-25	Initiated	Guggenheim	Buy	$32
Jul-30-25	Initiated	Roth Capital	Buy	$36
Jul-08-25	Upgrade	Barclays	Equal Weight → Overweight	$30
May-09-25	Upgrade	Citigroup	Neutral → Buy	$21
May-07-25	Upgrade	BofA Securities	Underperform → Buy
Oct-17-23	Downgrade	Goldman	Buy → Neutral	$25 → $16
Jul-27-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$30 → $21
Jul-27-23	Downgrade	Citigroup	Buy → Neutral	$28 → $22
May-02-23	Downgrade	Barclays	Overweight → Equal Weight
Mar-31-23	Upgrade	Loop Capital	Hold → Buy	$23
Jan-17-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-07-22	Resumed	Jefferies	Buy	$40 → $45
Jun-27-22	Upgrade	Goldman	Neutral → Buy	$31 → $32
Nov-15-21	Downgrade	Goldman	Buy → Neutral	$59 → $57
Nov-12-21	Downgrade	BofA Securities	Buy → Underperform	$63 → $50
Oct-14-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$70
Aug-27-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$58 → $57
Jan-11-21	Downgrade	Loop Capital	Buy → Hold
Nov-18-20	Downgrade	Berenberg	Buy → Hold	$42
Feb-04-20	Initiated	BMO Capital Markets	Market Perform

Show Previous Ratings

Feb-10-26 11:43AM	CVS Beats on Q4 Earnings and Revenues but Shares Slide in Pre-Market (Zacks)
11:11AM	ZBH Q4 Earnings & Revenues Top Estimates, Stock Up in Pre-Market (Zacks)
Feb-06-26 09:31AM	Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips (Zacks)
Feb-05-26 09:25AM	STE Q3 Earnings Meet, Revenues Beat, Stock Dips in Aftermarket Trading (Zacks)
Feb-04-26 12:15PM	BSX Stock Dips in Premarket Trading Despite Q4 Earnings, Revenue Beat (Zacks)
09:34AM	Loading…
09:34AM	TECH Q2 Earnings & Revenues Beat Estimates, Operating Margin Up (Zacks)
Feb-01-26 11:43PM	1 Cash-Producing Stock on Our Watchlist and 2 We Ignore (StockStory)
Jan-30-26 08:05AM	Church & Dwight (CHD) Q4 Earnings and Revenues Beat Estimates (Zacks)
Jan-29-26 08:48AM	Thermo Fisher's Q4 Earnings & Revenues Top Estimates, Stock Climbs (Zacks)
Jan-28-26 09:55AM	Wall Street Analysts Predict a 25.68% Upside in National Vision (EYE): Here's What You Should Know (Zacks)
09:50AM	National Vision (EYE) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
Jan-27-26 06:25PM	National Vision CEO Alex Wilkes on Leveraging Brands: ICR Conference 2026 (Exec Edge)
Jan-26-26 12:10PM	Will National Vision (EYE) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-25-26 11:34PM	1 Volatile Stock with Exciting Potential and 2 We Avoid (StockStory)
Jan-22-26 09:49AM	Abbott's Q4 Earnings Meet Estimates, Revenues Miss, Stock Falls (Zacks)
09:40AM	Loading…
09:40AM	Is The Estee Lauder Companies (EL) Outperforming Other Consumer Staples Stocks This Year? (Zacks)
Jan-16-26 07:50AM	National Vision price target raised to $30 from $26 at Morgan Stanley (TipRanks)
Jan-15-26 03:46PM	National Vision (EYE) Stock Trades Up, Here Is Why (StockStory)
02:36PM	Sneak Preview of 33 C-Suite Interviews at ICR Conference 2026 (Exec Edge)
Jan-13-26 07:00AM	National Vision Reaffirms Fiscal 2025 Outlook Ahead of Participation at the ICR Conference (Business Wire)
Jan-11-26 11:31PM	3 Russell 2000 Stocks We Think Twice About (StockStory)
Jan-07-26 06:07PM	CorpGov Showcases Conference Video Coverage Capabilities (CorpGov.com)
11:46AM	CorpGov to Host On-Site Interviews at ICR Conference 2026 (CorpGov.com)
Jan-06-26 04:05PM	National Vision Announces Participation in the 2026 ICR Conference (Business Wire)
Dec-30-25 11:31PM	3 High-Flying Stocks That Fall Short (StockStory)
Dec-19-25 09:09AM	National Vision Stock Surges 154.6% in a Year: What's Driving it? (Zacks)
Dec-18-25 11:32PM	1 Small-Cap Stock for Long-Term Investors and 2 Facing Challenges (StockStory)
11:30AM	Why Is Energizer (ENR) Up 12.8% Since Last Earnings Report? (Zacks)
Dec-16-25 10:36PM	Q3 Earnings Highs And Lows: National Vision (NASDAQ:EYE) Vs The Rest Of The Specialty Retail Stocks (StockStory)
Dec-10-25 11:03PM	3 Reasons EYE is Risky and 1 Stock to Buy Instead (StockStory)
11:30AM	Loading…
Dec-05-25 11:30AM	National Vision (EYE) Up 19.9% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-26-25 08:00AM	National Vision Announces Participation in Morgan Stanley Global Consumer & Retail Conference (Business Wire)
Nov-18-25 02:15PM	Why Are National Vision (EYE) Shares Soaring Today (StockStory)
Nov-17-25 06:45AM	National Vision Holdings, Inc. Details Transformation Strategy and Long-Term Financial Objectives Underpinning Bold Reinvention (Business Wire)
Nov-12-25 12:32AM	The 5 Most Interesting Analyst Questions From National Vision's Q3 Earnings Call (StockStory)
Nov-06-25 06:00PM	National Vision Holdings Inc (EYE) Q3 2025 Earnings Call Highlights: Strong Comp Growth and ... (GuruFocus.com)
09:30AM	National Vision (EYE) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
12:31AM	EYE Q3 Deep Dive: Strategy Shift Targets Higher-Value Optical Segments Amid Market Headwinds (StockStory)
Nov-05-25 12:25PM	Why National Vision (EYE) Stock Is Nosediving (StockStory)
07:20AM	National Vision (EYE) Q3 Earnings and Revenues Top Estimates (Zacks)
06:25AM	National Vision's (NASDAQ:EYE) Q3 Sales Beat Estimates (StockStory)
06:16AM	National Vision: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	National Vision Holdings, Inc. Reports Third Quarter 2025 Financial Results (Business Wire)
Nov-03-25 10:23PM	National Vision (EYE) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Oct-31-25 07:10AM	Newell Brands (NWL) Misses Q3 Earnings and Revenue Estimates (Zacks)
Oct-28-25 12:01AM	3 Reasons EYE is Risky and 1 Stock to Buy Instead (StockStory)
Oct-22-25 08:00AM	National Vision Holdings, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call (Business Wire)
Oct-09-25 11:31PM	Specialty Retail Q2 Earnings: National Vision (NASDAQ:EYE) Simply the Best (StockStory) -6.65%
Oct-07-25 09:01AM	National Vision Launches 2025-2026 Scholarship Program, Spotlighting Technology's Role in Access to Eye Care (Business Wire)
Oct-01-25 12:39AM	3 Russell 2000 Stocks Walking a Fine Line (StockStory)
Sep-30-25 12:32AM	1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm (StockStory)
Sep-25-25 09:31AM	National Vision Gains 166.5% in a Year: What's Driving the Rally? (Zacks)
Sep-19-25 05:09AM	National Vision (EYE) Surges 6.4%: Is This an Indication of Further Gains? (Zacks)
Sep-02-25 04:40PM	National Vision, Freshpet, Gray Television, Stratasys, and Erie Indemnity Shares Plummet, What You Need To Know (StockStory)
Aug-20-25 08:00AM	National Vision Announces Participation in Goldman Sachs Global Retailing Conference (Business Wire)
Aug-19-25 09:00AM	America's Best Unveils Major Brand Transformation: VML Relaunches Eye Care Retailer's Identity with the Powerful Message "Every Eye Deserves Better" (PR Newswire)
Aug-13-25 01:35AM	The 5 Most Interesting Analyst Questions From National Vision's Q2 Earnings Call (StockStory)
Aug-12-25 08:22AM	EYE Stock Gains on Q2 Earnings and Revenue Beat, '25 View Up (Zacks)
03:06AM	EYE Q2 Deep Dive: Brand Revamp, Pricing Actions, and Managed Care Drive Results (StockStory)
Aug-08-25 03:43PM	2 High-Flying Stocks with Impressive Fundamentals and 1 Facing Challenges (StockStory) -6.33%
Aug-07-25 01:00PM	National Vision (EYE) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
Aug-06-25 07:10AM	National Vision (EYE) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:19AM	National Vision (NASDAQ:EYE) Reports Strong Q2, Stock Soars (StockStory)
06:09AM	National Vision: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	National Vision Holdings, Inc. Reports Second Quarter 2025 Financial Results (Business Wire)
Aug-05-25 09:44AM	Earnings To Watch: National Vision Holdings Inc (EYE) Reports Q2 2025 Result (GuruFocus.com)
08:00AM	National Vision, Inc. Unveils Bold New Brand Identity as Part of Strategic Transformation (PR Newswire)
Aug-04-25 11:02PM	National Vision (EYE) Q2 Earnings: What To Expect (StockStory)
Aug-01-25 11:13AM	Colgate Tops Q2 Earnings & Sales Estimates, Tweaks Organic Sales View (Zacks)
Jul-30-25 09:40AM	Peloton upgraded, Booking downgraded: Wall Street's top analyst calls (The Fly)
08:21AM	National Vision Releases Annual Sustainability Report Highlighting 2024 Progress (Business Wire)
Jul-29-25 08:02AM	National Vision Celebrates 11 Years of Supporting NOSA Students with $7,000 in Scholarships (Business Wire)
Jul-25-25 09:40AM	Are Consumer Staples Stocks Lagging National Vision (EYE) This Year? (Zacks)
Jul-23-25 08:00AM	National Vision Holdings, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call (Business Wire)
Jul-15-25 12:38AM	3 Small-Cap Stocks in the Doghouse (StockStory)
Jul-13-25 11:34PM	Q1 Specialty Retail Earnings: National Vision (NASDAQ:EYE) Earns Top Marks (StockStory)
Jul-11-25 09:15AM	National Vision Holdings, Inc. (EYE) Hits Fresh High: Is There Still Room to Run? (Zacks)
Jul-09-25 09:40AM	Is National Vision (EYE) Stock Outpacing Its Consumer Staples Peers This Year? (Zacks)
01:31AM	The Top 5 Analyst Questions From National Vision's Q1 Earnings Call (StockStory)
Jul-08-25 01:50PM	National Vision (EYE) Stock Is Up, What You Need To Know (StockStory) +6.00%
Jun-24-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
08:35AM	Is This the Right Time to Hold EYE Stock in Your Portfolio? (Zacks)
Jun-19-25 12:33AM	1 Russell 2000 Stock with Competitive Advantages and 2 to Keep Off Your Radar (StockStory)
Jun-10-25 09:59AM	EYE Q1 Earnings Call: National Vision Discusses Transformation Strategy, Leadership Transition, and Tariff Impact (StockStory)
12:37AM	1 Cash-Producing Stock to Research Further and 2 to Be Wary Of (StockStory)
Jun-06-25 11:31AM	Why Is National Vision (EYE) Up 25.1% Since Last Earnings Report? (Zacks)
Jun-02-25 09:50AM	Here's Why National Vision (EYE) is a Strong Momentum Stock (Zacks) +6.97%
May-29-25 12:35AM	1 High-Flying Stock with Exciting Potential and 2 to Think Twice About (StockStory)
May-22-25 12:00AM	3 Reasons EYE is Risky and 1 Stock to Buy Instead (StockStory)
May-21-25 04:05PM	National Vision Announces Participation in William Blair Growth Stock Conference (Business Wire)
May-20-25 11:35AM	Art Basel Qatar to Debut in Doha in February (WWD)
May-17-25 07:00AM	MarketBeat Week in Review - 05/12 - 05/16 (MarketBeat)
May-16-25 07:30AM	3 Small-Cap Stocks With Room to Run Despite Tariff Headwinds (MarketBeat)
May-15-25 04:05PM	National Vision Announces Settlement of 2025 Convertible Senior Notes (Business Wire)
09:50AM	Why National Vision (EYE) is a Top Momentum Stock for the Long-Term (Zacks)
08:47AM	Keep Your EYE on This Stock, It Just Got a Rare Double Upgrade (MarketBeat)
May-14-25 03:44PM	National Vision Just Skyrocketed. A Big Shareholder Says It Isnt Done. (Barrons.com)
May-08-25 07:54AM	EYE Q1 Earnings and Revenues Beat, Gross Margin Up, Stock Surges (Zacks) +6.85%
03:15AM	National Vision Holdings Inc (EYE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-07-25 04:12PM	National Vision's Q1 results earns double upgrade at BofA (Seeking Alpha) +17.10%

National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate and Other. The Owned and Host segment offers America's Best and Eyeglass World brands. The Legacy segment includes inventory and lab processing services. The Corporate and Other segment relates to the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FAHS L READE	Executive Chairman	Sep 16 '25	Sale	23.93	10,598	253,610	532,195	Sep 17 04:11 PM
FAHS L READE	Executive Chairman	Sep 15 '25	Sale	23.81	2,002	47,668	542,793	Sep 17 04:11 PM
FAHS L READE	Officer	Sep 16 '25	Proposed Sale	23.93	10,598	253,629		Sep 16 04:16 PM
FAHS L READE	Officer	Sep 15 '25	Proposed Sale	23.81	2,002	47,670		Sep 15 04:12 PM
FAHS L READE	Executive Chairman	Aug 28 '25	Sale	24.33	137,400	3,343,174	544,795	Aug 29 04:16 PM
FAHS L READE	Officer	Aug 28 '25	Proposed Sale	24.33	137,400	3,343,335		Aug 28 04:16 PM
Molony Megan	SVP, CHIEF MERCH. & MC OFFICER	May 15 '25	Option Exercise	15.07	12,206	183,944	16,181	May 16 04:30 PM
Molony Megan	SVP, CHIEF MERCH. & MC OFFICER	May 14 '25	Sale	18.90	3,900	73,710	3,975	May 16 04:30 PM
Moore Patrick R.	Former Officer	May 16 '25	Proposed Sale	19.13	15,983	305,751		May 16 02:29 PM
Molony Megan	Officer	May 15 '25	Proposed Sale	18.60	10,581	196,807		May 15 01:11 PM
Acharya Ravi	SVP, Chief Technology Officer	May 13 '25	Sale	18.75	12,000	225,060	11,700	May 14 04:37 PM
Molony Megan	Officer	May 14 '25	Proposed Sale	18.90	3,900	73,710		May 14 11:53 AM
Acharya Ravi	Officer	May 13 '25	Proposed Sale	18.75	12,000	225,060		May 13 03:34 PM
Rasmussen Melissa	Former Officer	May 07 '25	Proposed Sale	15.51	28,869	447,698		May 07 05:03 PM
VanDette Joseph	SVP, Chief Marketing Officer	Mar 01 '25	Sale	12.71	1,179	14,985	10,444	Mar 04 04:50 PM

RXST

RxSight Inc

COO

Cooper Companies, Inc

STAA

Staar Surgical Co

WRBY

Warby Parker Inc

EYE

National Vision Holdings Inc

Upgrade your FINVIZ experience